(Q37828061)

23 August 2017

1 reference

title

The contribution of hypertension to diabetic nephropathy and retinopathy: the role of inflammation and oxidative stress (English)

1 reference

23 August 2017

main subject

arterial hypertension

0 references

0 references

1 reference

José Butori Lopes de Faria

series ordinal

1

1 reference

23 August 2017

Kamila Cristina Silva

series ordinal

2

1 reference

23 August 2017

Jacqueline Mendonça Lopes de Faria

series ordinal

3

1 reference

23 August 2017

publication date

13 January 2011

1 reference

23 August 2017

published in

Hypertension Research

1 reference

23 August 2017

volume

34

1 reference

23 August 2017

issue

4

1 reference

23 August 2017

page(s)

413-422

1 reference

Controlling hypertension in diabetes

23 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.263

Additive effects of glycaemia and blood pressure exposure on risk of complications in type 2 diabetes: a prospective observational study (UKPDS 75).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.263

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.263

Combined effects of routine blood pressure lowering and intensive glucose control on macrovascular and microvascular outcomes in patients with type 2 diabetes: New results from the ADVANCE trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.263

Mechanisms of diabetic nephropathy: role of hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.263

Effects of aggressive blood pressure control in normotensive type 2 diabetic patients on albuminuria, retinopathy and strokes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.263

Blood pressure lowering for the prevention and treatment of diabetic kidney disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.263

The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XXII the twenty-five-year progression of retinopathy in persons with type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.263

The 25-year incidence of visual impairment in type 1 diabetes mellitus the wisconsin epidemiologic study of diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.263

Rapid development of glomerulosclerosis in diabetic Dahl salt-sensitive rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.263

The effects of Goldblatt hypertension on development of the glomerular lesions of diabetes mellitus in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.263

The presence of genetic hypertension stimulates early renal accumulation of fibronectin in experimental diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.263

p27(Kip1) Knockout mice are protected from diabetic nephropathy: evidence for p27(Kip1) haplotype insufficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.263

The genetics of hypertension modifies the renal cell replication response induced by experimental diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.263

The renal vascular response to diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.263

The effect of experimental hypertension on retinal vascular autoregulation in humans: a mechanism for the progression of diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.263

Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.263

Cyclic stretch and hypertension induce retinal expression of vascular endothelial growth factor and vascular endothelial growth factor receptor-2: potential mechanisms for exacerbation of diabetic retinopathy by hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.263

Stretch-induced retinal vascular endothelial growth factor expression is mediated by phosphatidylinositol 3-kinase and protein kinase C (PKC)-zeta but not by stretch-induced ERK1/2, Akt, Ras, or classical/novel PKC pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.263

Cyclic stretch-induced reactive oxygen species generation enhances apoptosis in retinal pericytes through c-jun NH2-terminal kinase activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.263

Accelerated death of retinal microvascular cells in human and experimental diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.263

Pericyte migration: a novel mechanism of pericyte loss in experimental diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.263

Regulation of extracellular matrix by mechanical stress in rat glomerular mesangial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.263

TGF-beta receptor expression and binding in rat mesangial cells: modulation by glucose and cyclic mechanical strain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.263

Blood levels of alpha-1-antichymotrypsin and risk factors for Alzheimer's disease: effects of gender and apolipoprotein E genotype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.263

The MCP-1/CCR2 system has direct proinflammatory effects in human mesangial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.263

Mechanical stretch induces monocyte chemoattractant activity via an NF-kappaB-dependent monocyte chemoattractant protein-1-mediated pathway in human mesangial cells: inhibition by rosiglitazone

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.263

Adhesion of U-937 monocytes induces cytotoxic damage and subsequent proliferation of cultured human mesangial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.263

GLUT-1 overexpression: Link between hemodynamic and metabolic factors in glomerular injury?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.263

Overexpression of glucose transporters in rat mesangial cells cultured in a normal glucose milieu mimics the diabetic phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.263

The podocyte's response to injury: role in proteinuria and glomerulosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.263

Stretch, tension and adhesion - adaptive mechanisms of the actin cytoskeleton in podocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.263

Mechanical forces and TGFbeta1 reduce podocyte adhesion through alpha3beta1 integrin downregulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.263

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.263

Activation of a local renin angiotensin system in podocytes by glucose

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.263

Activation of a local tissue angiotensin system in podocytes by mechanical strain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.263

Stretch reduces nephrin expression via an angiotensin II-AT(1)-dependent mechanism in human podocytes: effect of rosiglitazone

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.263

Nephrin expression is reduced in human diabetic nephropathy: evidence for a distinct role for glycated albumin and angiotensin II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.263

Irbesartan normalises the deficiency in glomerular nephrin expression in a model of diabetes and hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.263

Nox4 NAD(P)H oxidase mediates hypertrophy and fibronectin expression in the diabetic kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.263

The pathobiology of diabetic complications: a unifying mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.263

Redefining oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.263

Measuring reactive species and oxidative damage in vivo and in cell culture: how should you do it and what do the results mean?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.263

Evaluation of Urinary 8-Hydroxydeoxy-Guanosine as a Novel Biomarker of Macrovascular Complications in Type 2 Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.263

Urinary excretion of 8-oxo-7, 8-dihydro-2'-deoxyguanosine as a predictor of the development of diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.263

Low-dose erythropoietin inhibits oxidative stress and early vascular changes in the experimental diabetic retina

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.263

Mycophenolate mofetil prevents the development of glomerular injury in experimental diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.263

Erythromycin ameliorates renal injury via anti-inflammatory effects in experimental diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.263

Methotrexate prevents renal injury in experimental diabetic rats via anti-inflammatory actions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.263

Intercellular Adhesion Molecule-1–Deficient Mice Are Resistant Against Renal Injury After Induction of Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.263

Monocyte chemoattractant protein-1 promotes the development of diabetic renal injury in streptozotocin-treated mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.263

Therapies for hyperglycaemia-induced diabetic complications: from animal models to clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.263

Mechanisms of disease: oxidative stress and inflammation in the pathogenesis of hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.263

Hypertension increases pro-oxidant generation and decreases antioxidant defense in the kidney in early diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.263

Attenuation of renal injury in db/db mice overexpressing superoxide dismutase: evidence for reduced superoxide-nitric oxide interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.263

Reduction of renal superoxide dismutase in progressive diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.263

Antioxidant SOD mimetic prevents NADPH oxidase-induced oxidative stress and renal damage in the early stage of experimental diabetes and hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.263

Green tea (Camellia sinensis) attenuates nephropathy by downregulating Nox4 NADPH oxidase in diabetic spontaneously hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.263

Oxidative stress and diabetic retinopathy: pathophysiological mechanisms and treatment perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.263

Effect of long-term administration of alpha-lipoic acid on retinal capillary cell death and the development of retinopathy in diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.263

Diabetes-induced nitrative stress in the retina, and correction by aminoguanidine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.263

Arterial hypertension exacerbates oxidative stress in early diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.263

Exogenous SOD mimetic tempol ameliorates the early retinal changes reestablishing the redox status in diabetic hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.263

Reduction of inducible nitric oxide synthase via angiotensin receptor blocker prevents the oxidative retinal damage in diabetic hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.263

Diabetic retinal neurodegeneration is associated with mitochondrial oxidative stress and is improved by an angiotensin receptor blocker in a model combining hypertension and diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.263

Blockade of AT1 receptor reduces apoptosis, inflammation, and oxidative stress in normotensive rats with intracerebral hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.263

The role of the renin-angiotensin-aldosterone system in diabetes and its vascular complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.263

Renal and retinal effects of enalapril and losartan in type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.263

Effect of candesartan on prevention (DIRECT-Prevent 1) and progression (DIRECT-Protect 1) of retinopathy in type 1 diabetes: randomised, placebo-controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.263

Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.263

The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.263

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.263

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.263

Effect of candesartan on progression and regression of retinopathy in type 2 diabetes (DIRECT-Protect 2): a randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.263

Addition of angiotensin receptor blockade or mineralocorticoid antagonism to maximal angiotensin-converting enzyme inhibition in diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.263

Effect of eplerenone, enalapril and their combination treatment on diabetic nephropathy in type II diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.263

Spironolactone prevents early renal injury in streptozotocin-induced diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.263

Spironolactone prevents diabetic nephropathy through an anti-inflammatory mechanism in type 2 diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.263

Diabetes causes inhibition of glucose-6-phosphate dehydrogenase via activation of PKA, which contributes to oxidative stress in rat kidney cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.263

Glucose-6-phosphate dehydrogenase overexpression decreases endothelial cell oxidant stress and increases bioavailable nitric oxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.263

Glucose-6-phosphate dehydrogenase-deficient mice have increased renal oxidative stress and increased albuminuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.263

Aldosterone impairs vascular reactivity by decreasing glucose-6-phosphate dehydrogenase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.263

Identification of a retinal aldosterone system and the protective effects of mineralocorticoid receptor antagonism on retinal vascular pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.263

New pathways of the renin-angiotensin system: the role of ACE2 in cardiovascular pathophysiology and therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.263

Human recombinant ACE2 reduces the progression of diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.263

Identification of angiotensin converting enzyme 2 in the rodent retina.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.263

Activities of angiotensin-converting enzymes ACE1 and ACE2 and inhibition by bioactive peptides in porcine ocular tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.263

ACE2, a new regulator of the renin-angiotensin system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.263

Characterization of renal angiotensin-converting enzyme 2 in diabetic nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.263

A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.263

Decreased glomerular and tubular expression of ACE2 in patients with type 2 diabetes and kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.263

Discrepancy between intrarenal messenger RNA and protein expression of ACE and ACE2 in human diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.263

ACE and ACE2 activity in diabetic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.263

Loss of ACE2 accelerates time-dependent glomerular and tubulointerstitial damage in streptozotocin-induced diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.263

RILLKKMPSV influences the vasculature, neurons and glia, and (pro)renin receptor expression in the retina

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.263

(Pro)renin receptor: a treatment target for diabetic retinopathy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.263

Prorenin and the (pro)renin receptor in ocular pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.263

Effects of aliskiren on blood pressure, albuminuria, and (pro)renin receptor expression in diabetic TG(mRen-2)27 rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.263

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.263

Renin, prorenin, and immunoreactive renin in vitreous fluid from eyes with and without diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.263

Critical review of prorenin and (pro)renin receptor research

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.263

Glucose promotes the production of interleukine-1beta and cyclooxygenase-2 in mesangial cells via enhanced (Pro)renin receptor expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.263

(Pro)renin receptor-mediated signal transduction and tissue renin-angiotensin system contribute to diabetes-induced retinal inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.263

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.263

The RAAS in the pathogenesis and treatment of diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.263

Angiotensin and diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.263

Effect of systemic medications on onset and progression of diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.263

Effect of a multifactorial intervention on mortality in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.263

Effect of red wine on urinary protein, 8-hydroxydeoxyguanosine, and liver-type fatty acid-binding protein excretion in patients with diabetic nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.263

Effects of low habitual cocoa intake on blood pressure and bioactive nitric oxide: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.263

Paradoxical effects of green tea (Camellia sinensis) and antioxidant vitamins in diabetic rats: improved retinopathy and renal mitochondrial defects but deterioration of collagen matrix glycoxidation and cross-linking

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.263

Impact of Blood Pressure Control and Angiotensin-Converting Enzyme Inhibitor Therapy on New-Onset Microalbuminuria in Type 2 Diabetes: A Post Hoc Analysis of the BENEDICT Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.263

Prevention of hypertension abrogates early inflammatory events in the retina of diabetic hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.263

Hypertension Increases Retinal Inflammation in Experimental Diabetes: A Possible Mechanism for Aggravation of Diabetic Retinopathy by Hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.263

Elevated blood pressure among U.S. adults with diabetes, 1988-1994

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.263

7 January 2021

Prevalence of Arterial Hypertension in Diabetic Patients Before and After the JNC-V

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.263

7 January 2021

Masked hypertension, nocturnal blood pressure and retinopathy in normotensive patients with type 1 diabetes

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.263

7 January 2021

Effects of genetic hypertension on diabetic nephropathy in the rat--functional and structural characteristics

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.263

7 January 2021

Aminoguanidine inhibits the development of accelerated diabetic retinopathy in the spontaneous hypertensive rat

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.263

7 January 2021

Mechanical stretch-induced fibronectin and transforming growth factor-beta1 production in human mesangial cells is p38 mitogen-activated protein kinase-dependent

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.263

7 January 2021

Effects of mechanical stress and high glucose on pericyte proliferation, apoptosis and contractile phenotype

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.263

7 January 2021

Role of glomerular mechanical strain in the pathogenesis of diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.263

7 January 2021

Vascular endothelial growth factor activates MAP kinase and enhances collagen synthesis in human mesangial cells

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.263

7 January 2021

Structural alterations to the podocyte are related to proteinuria in type 2 diabetic patients

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.263

7 January 2021

Prevention of hypertension with or without renin-angiotensin system inhibition precludes nephrin loss in the early stage of experimental diabetes mellitus

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.263

7 January 2021

Oxidative DNA damage in diabetes mellitus: its association with diabetic complications

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.263

7 January 2021

The role of macrophages in diabetic glomerulosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.263

7 January 2021

Interleukin-8, monocyte chemoattractant protein-1 and IL-10 in the vitreous fluid of patients with proliferative diabetic retinopathy

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.263

7 January 2021

The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.263

7 January 2021

Aldosterone blockade attenuates urinary monocyte chemoattractant protein-1 and oxidative stress in patients with type 2 diabetes complicated by diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.263

7 January 2021

Glucose-6-phosphate dehydrogenase deficiency promotes endothelial oxidant stress and decreases endothelial nitric oxide bioavailability.

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.263

7 January 2021

The mineralocorticoid receptor: insights into its molecular and (patho)physiological biology

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.263

7 January 2021

Pivotal role of the renin/prorenin receptor in angiotensin II production and cellular responses to renin

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.263

7 January 2021

Inhibition of diabetic nephropathy by a decoy peptide corresponding to the "handle" region for nonproteolytic activation of prorenin

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.263

7 January 2021

Regression of nephropathy developed in diabetes by (Pro)renin receptor blockade

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.263

7 January 2021

Effects of antihypertensive drugs or glycemic control on antioxidant enzyme activities in spontaneously hypertensive rats with diabetes

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.263

7 January 2021

Angiotensin II Type 1 Receptor Blockers Reduce Urinary Angiotensinogen Excretion and the Levels of Urinary Markers of Oxidative Stress and Inflammation in Patients with Type 2 Diabetic Nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.263

7 January 2021

Identifiers

DOI

10.1038/HR.2010.263

1 reference

23 August 2017

1 reference